Global Follicular Lymphoma Treatment Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Follicular Lymphoma Treatment Market Size 2017-2028

2.1.2 Follicular Lymphoma Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Follicular Lymphoma Treatment Segment by Type

2.2.1 Chemotherapy

2.2.2 Radiotherapy

2.2.3 Monoclonal Antibodies

2.2.4 Stem Cell Transplantation

2.3 Follicular Lymphoma Treatment Market Size by Type

2.3.1 Follicular Lymphoma Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Follicular Lymphoma Treatment Market Size Market Share by Type (2017-2022)

2.4 Follicular Lymphoma Treatment Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Follicular Lymphoma Treatment Market Size by Application

2.5.1 Follicular Lymphoma Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Follicular Lymphoma Treatment Market Size Market Share by Application (2017-2022)

3 Follicular Lymphoma Treatment Market Size by Player

3.1 Follicular Lymphoma Treatment Market Size Market Share by Players

3.1.1 Global Follicular Lymphoma Treatment Revenue by Players (2020-2022)

3.1.2 Global Follicular Lymphoma Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Follicular Lymphoma Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Follicular Lymphoma Treatment by Regions

4.1 Follicular Lymphoma Treatment Market Size by Regions (2017-2022)

4.2 Americas Follicular Lymphoma Treatment Market Size Growth (2017-2022)

4.3 APAC Follicular Lymphoma Treatment Market Size Growth (2017-2022)

4.4 Europe Follicular Lymphoma Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Follicular Lymphoma Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Follicular Lymphoma Treatment Market Size by Country (2017-2022)

5.2 Americas Follicular Lymphoma Treatment Market Size by Type (2017-2022)

5.3 Americas Follicular Lymphoma Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Follicular Lymphoma Treatment Market Size by Region (2017-2022)

6.2 APAC Follicular Lymphoma Treatment Market Size by Type (2017-2022)

6.3 APAC Follicular Lymphoma Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Follicular Lymphoma Treatment by Country (2017-2022)

7.2 Europe Follicular Lymphoma Treatment Market Size by Type (2017-2022)

7.3 Europe Follicular Lymphoma Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Follicular Lymphoma Treatment by Region (2017-2022)

8.2 Middle East & Africa Follicular Lymphoma Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Follicular Lymphoma Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Follicular Lymphoma Treatment Market Forecast

10.1 Global Follicular Lymphoma Treatment Forecast by Regions (2023-2028)

10.1.1 Global Follicular Lymphoma Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Follicular Lymphoma Treatment Forecast

10.1.3 APAC Follicular Lymphoma Treatment Forecast

10.1.4 Europe Follicular Lymphoma Treatment Forecast

10.1.5 Middle East & Africa Follicular Lymphoma Treatment Forecast

10.2 Americas Follicular Lymphoma Treatment Forecast by Country (2023-2028)

10.2.1 United States Follicular Lymphoma Treatment Market Forecast

10.2.2 Canada Follicular Lymphoma Treatment Market Forecast

10.2.3 Mexico Follicular Lymphoma Treatment Market Forecast

10.2.4 Brazil Follicular Lymphoma Treatment Market Forecast

10.3 APAC Follicular Lymphoma Treatment Forecast by Region (2023-2028)

10.3.1 China Follicular Lymphoma Treatment Market Forecast

10.3.2 Japan Follicular Lymphoma Treatment Market Forecast

10.3.3 Korea Follicular Lymphoma Treatment Market Forecast

10.3.4 Southeast Asia Follicular Lymphoma Treatment Market Forecast

10.3.5 India Follicular Lymphoma Treatment Market Forecast

10.3.6 Australia Follicular Lymphoma Treatment Market Forecast

10.4 Europe Follicular Lymphoma Treatment Forecast by Country (2023-2028)

10.4.1 Germany Follicular Lymphoma Treatment Market Forecast

10.4.2 France Follicular Lymphoma Treatment Market Forecast

10.4.3 UK Follicular Lymphoma Treatment Market Forecast

10.4.4 Italy Follicular Lymphoma Treatment Market Forecast

10.4.5 Russia Follicular Lymphoma Treatment Market Forecast

10.5 Middle East & Africa Follicular Lymphoma Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Follicular Lymphoma Treatment Market Forecast

10.5.2 South Africa Follicular Lymphoma Treatment Market Forecast

10.5.3 Israel Follicular Lymphoma Treatment Market Forecast

10.5.4 Turkey Follicular Lymphoma Treatment Market Forecast

10.5.5 GCC Countries Follicular Lymphoma Treatment Market Forecast

10.6 Global Follicular Lymphoma Treatment Forecast by Type (2023-2028)

10.7 Global Follicular Lymphoma Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Boehringer Ingelheim GmbH

11.1.1 Boehringer Ingelheim GmbH Company Information

11.1.2 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Product Offered

11.1.3 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Boehringer Ingelheim GmbH Main Business Overview

11.1.5 Boehringer Ingelheim GmbH Latest Developments

11.2 Bristol-Myers Squibb Company

11.2.1 Bristol-Myers Squibb Company Company Information

11.2.2 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Product Offered

11.2.3 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Bristol-Myers Squibb Company Main Business Overview

11.2.5 Bristol-Myers Squibb Company Latest Developments

11.3 Celgene Corporation

11.3.1 Celgene Corporation Company Information

11.3.2 Celgene Corporation Follicular Lymphoma Treatment Product Offered

11.3.3 Celgene Corporation Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Celgene Corporation Main Business Overview

11.3.5 Celgene Corporation Latest Developments

11.4 Celldex Therapeutics, Inc.

11.4.1 Celldex Therapeutics, Inc. Company Information

11.4.2 Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Product Offered

11.4.3 Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Celldex Therapeutics, Inc. Main Business Overview

11.4.5 Celldex Therapeutics, Inc. Latest Developments

11.5 Celltrion, Inc.

11.5.1 Celltrion, Inc. Company Information

11.5.2 Celltrion, Inc. Follicular Lymphoma Treatment Product Offered

11.5.3 Celltrion, Inc. Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Celltrion, Inc. Main Business Overview

11.5.5 Celltrion, Inc. Latest Developments

11.6 Cellular Biomedicine Group, Inc.

11.6.1 Cellular Biomedicine Group, Inc. Company Information

11.6.2 Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Product Offered

11.6.3 Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Cellular Biomedicine Group, Inc. Main Business Overview

11.6.5 Cellular Biomedicine Group, Inc. Latest Developments

11.7 Coherus BioSciences, Inc.

11.7.1 Coherus BioSciences, Inc. Company Information

11.7.2 Coherus BioSciences, Inc. Follicular Lymphoma Treatment Product Offered

11.7.3 Coherus BioSciences, Inc. Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Coherus BioSciences, Inc. Main Business Overview

11.7.5 Coherus BioSciences, Inc. Latest Developments

11.8 CTI BioPharma Corp.

11.8.1 CTI BioPharma Corp. Company Information

11.8.2 CTI BioPharma Corp. Follicular Lymphoma Treatment Product Offered

11.8.3 CTI BioPharma Corp. Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 CTI BioPharma Corp. Main Business Overview

11.8.5 CTI BioPharma Corp. Latest Developments

11.9 Curis, Inc.

11.9.1 Curis, Inc. Company Information

11.9.2 Curis, Inc. Follicular Lymphoma Treatment Product Offered

11.9.3 Curis, Inc. Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Curis, Inc. Main Business Overview

11.9.5 Curis, Inc. Latest Developments

11.10 Dynavax Technologies Corporation

11.10.1 Dynavax Technologies Corporation Company Information

11.10.2 Dynavax Technologies Corporation Follicular Lymphoma Treatment Product Offered

11.10.3 Dynavax Technologies Corporation Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Dynavax Technologies Corporation Main Business Overview

11.10.5 Dynavax Technologies Corporation Latest Developments

11.11 Eisai

11.11.1 Eisai Company Information

11.11.2 Eisai Follicular Lymphoma Treatment Product Offered

11.11.3 Eisai Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Eisai Main Business Overview

11.11.5 Eisai Latest Developments

11.12 EpiZyme, Inc.

11.12.1 EpiZyme, Inc. Company Information

11.12.2 EpiZyme, Inc. Follicular Lymphoma Treatment Product Offered

11.12.3 EpiZyme, Inc. Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 EpiZyme, Inc. Main Business Overview

11.12.5 EpiZyme, Inc. Latest Developments

11.13 F. Hoffmann-La Roche Ltd.

11.13.1 F. Hoffmann-La Roche Ltd. Company Information

11.13.2 F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Product Offered

11.13.3 F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 F. Hoffmann-La Roche Ltd. Main Business Overview

11.13.5 F. Hoffmann-La Roche Ltd. Latest Developments

11.14 Genentech, Inc.

11.14.1 Genentech, Inc. Company Information

11.14.2 Genentech, Inc. Follicular Lymphoma Treatment Product Offered

11.14.3 Genentech, Inc. Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Genentech, Inc. Main Business Overview

11.14.5 Genentech, Inc. Latest Developments

11.15 Gilead Sciences, Inc.

11.15.1 Gilead Sciences, Inc. Company Information

11.15.2 Gilead Sciences, Inc. Follicular Lymphoma Treatment Product Offered

11.15.3 Gilead Sciences, Inc. Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Gilead Sciences, Inc. Main Business Overview

11.15.5 Gilead Sciences, Inc. Latest Developments

11.16 GlaxoSmithKline Plc

11.16.1 GlaxoSmithKline Plc Company Information

11.16.2 GlaxoSmithKline Plc Follicular Lymphoma Treatment Product Offered

11.16.3 GlaxoSmithKline Plc Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 GlaxoSmithKline Plc Main Business Overview

11.16.5 GlaxoSmithKline Plc Latest Developments

11.17 Hutchison MediPharma Limited

11.17.1 Hutchison MediPharma Limited Company Information

11.17.2 Hutchison MediPharma Limited Follicular Lymphoma Treatment Product Offered

11.17.3 Hutchison MediPharma Limited Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Hutchison MediPharma Limited Main Business Overview

11.17.5 Hutchison MediPharma Limited Latest Developments

11.18 Immune Design Corp.

11.18.1 Immune Design Corp. Company Information

11.18.2 Immune Design Corp. Follicular Lymphoma Treatment Product Offered

11.18.3 Immune Design Corp. Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Immune Design Corp. Main Business Overview

11.18.5 Immune Design Corp. Latest Developments

11.19 ImmunoGen, Inc.

11.19.1 ImmunoGen, Inc. Company Information

11.19.2 ImmunoGen, Inc. Follicular Lymphoma Treatment Product Offered

11.19.3 ImmunoGen, Inc. Follicular Lymphoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 ImmunoGen, Inc. Main Business Overview

11.19.5 ImmunoGen, Inc. Latest Developments

12 Research Findings and Conclusion

Table 1. Follicular Lymphoma Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Chemotherapy

Table 3. Major Players of Radiotherapy

Table 4. Major Players of Monoclonal Antibodies

Table 5. Major Players of Stem Cell Transplantation

Table 6. Follicular Lymphoma Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Follicular Lymphoma Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Follicular Lymphoma Treatment Market Size Market Share by Type (2017-2022)

Table 9. Follicular Lymphoma Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Follicular Lymphoma Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Follicular Lymphoma Treatment Market Size Market Share by Application (2017-2022)

Table 12. Global Follicular Lymphoma Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Follicular Lymphoma Treatment Revenue Market Share by Player (2020-2022)

Table 14. Follicular Lymphoma Treatment Key Players Head office and Products Offered

Table 15. Follicular Lymphoma Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Follicular Lymphoma Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Follicular Lymphoma Treatment Market Size Market Share by Regions (2017-2022)

Table 20. Americas Follicular Lymphoma Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Follicular Lymphoma Treatment Market Size Market Share by Country (2017-2022)

Table 22. Americas Follicular Lymphoma Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Follicular Lymphoma Treatment Market Size Market Share by Type (2017-2022)

Table 24. Americas Follicular Lymphoma Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Follicular Lymphoma Treatment Market Size Market Share by Application (2017-2022)

Table 26. APAC Follicular Lymphoma Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Follicular Lymphoma Treatment Market Size Market Share by Region (2017-2022)

Table 28. APAC Follicular Lymphoma Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Follicular Lymphoma Treatment Market Size Market Share by Type (2017-2022)

Table 30. APAC Follicular Lymphoma Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Follicular Lymphoma Treatment Market Size Market Share by Application (2017-2022)

Table 32. Europe Follicular Lymphoma Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Follicular Lymphoma Treatment Market Size Market Share by Country (2017-2022)

Table 34. Europe Follicular Lymphoma Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Follicular Lymphoma Treatment Market Size Market Share by Type (2017-2022)

Table 36. Europe Follicular Lymphoma Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Follicular Lymphoma Treatment Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Follicular Lymphoma Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Follicular Lymphoma Treatment Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Follicular Lymphoma Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Follicular Lymphoma Treatment Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Follicular Lymphoma Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Follicular Lymphoma Treatment Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Follicular Lymphoma Treatment

Table 45. Key Market Challenges & Risks of Follicular Lymphoma Treatment

Table 46. Key Industry Trends of Follicular Lymphoma Treatment

Table 47. Global Follicular Lymphoma Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Follicular Lymphoma Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Follicular Lymphoma Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Follicular Lymphoma Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Follicular Lymphoma Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Follicular Lymphoma Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 53. Boehringer Ingelheim GmbH Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 54. Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Product Offered

Table 55. Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Boehringer Ingelheim GmbH Main Business

Table 57. Boehringer Ingelheim GmbH Latest Developments

Table 58. Bristol-Myers Squibb Company Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 59. Bristol-Myers Squibb Company Follicular Lymphoma Treatment Product Offered

Table 60. Bristol-Myers Squibb Company Main Business

Table 61. Bristol-Myers Squibb Company Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Bristol-Myers Squibb Company Latest Developments

Table 63. Celgene Corporation Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 64. Celgene Corporation Follicular Lymphoma Treatment Product Offered

Table 65. Celgene Corporation Main Business

Table 66. Celgene Corporation Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Celgene Corporation Latest Developments

Table 68. Celldex Therapeutics, Inc. Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 69. Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Product Offered

Table 70. Celldex Therapeutics, Inc. Main Business

Table 71. Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Celldex Therapeutics, Inc. Latest Developments

Table 73. Celltrion, Inc. Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 74. Celltrion, Inc. Follicular Lymphoma Treatment Product Offered

Table 75. Celltrion, Inc. Main Business

Table 76. Celltrion, Inc. Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Celltrion, Inc. Latest Developments

Table 78. Cellular Biomedicine Group, Inc. Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 79. Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Product Offered

Table 80. Cellular Biomedicine Group, Inc. Main Business

Table 81. Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Cellular Biomedicine Group, Inc. Latest Developments

Table 83. Coherus BioSciences, Inc. Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 84. Coherus BioSciences, Inc. Follicular Lymphoma Treatment Product Offered

Table 85. Coherus BioSciences, Inc. Main Business

Table 86. Coherus BioSciences, Inc. Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Coherus BioSciences, Inc. Latest Developments

Table 88. CTI BioPharma Corp. Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 89. CTI BioPharma Corp. Follicular Lymphoma Treatment Product Offered

Table 90. CTI BioPharma Corp. Main Business

Table 91. CTI BioPharma Corp. Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. CTI BioPharma Corp. Latest Developments

Table 93. Curis, Inc. Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 94. Curis, Inc. Follicular Lymphoma Treatment Product Offered

Table 95. Curis, Inc. Main Business

Table 96. Curis, Inc. Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Curis, Inc. Latest Developments

Table 98. Dynavax Technologies Corporation Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 99. Dynavax Technologies Corporation Follicular Lymphoma Treatment Product Offered

Table 100. Dynavax Technologies Corporation Main Business

Table 101. Dynavax Technologies Corporation Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Dynavax Technologies Corporation Latest Developments

Table 103. Eisai Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 104. Eisai Follicular Lymphoma Treatment Product Offered

Table 105. Eisai Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Eisai Main Business

Table 107. Eisai Latest Developments

Table 108. EpiZyme, Inc. Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 109. EpiZyme, Inc. Follicular Lymphoma Treatment Product Offered

Table 110. EpiZyme, Inc. Main Business

Table 111. EpiZyme, Inc. Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. EpiZyme, Inc. Latest Developments

Table 113. F. Hoffmann-La Roche Ltd. Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 114. F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Product Offered

Table 115. F. Hoffmann-La Roche Ltd. Main Business

Table 116. F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. F. Hoffmann-La Roche Ltd. Latest Developments

Table 118. Genentech, Inc. Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 119. Genentech, Inc. Follicular Lymphoma Treatment Product Offered

Table 120. Genentech, Inc. Main Business

Table 121. Genentech, Inc. Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Genentech, Inc. Latest Developments

Table 123. Gilead Sciences, Inc. Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 124. Gilead Sciences, Inc. Follicular Lymphoma Treatment Product Offered

Table 125. Gilead Sciences, Inc. Main Business

Table 126. Gilead Sciences, Inc. Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 127. Gilead Sciences, Inc. Latest Developments

Table 128. GlaxoSmithKline Plc Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 129. GlaxoSmithKline Plc Follicular Lymphoma Treatment Product Offered

Table 130. GlaxoSmithKline Plc Main Business

Table 131. GlaxoSmithKline Plc Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 132. GlaxoSmithKline Plc Latest Developments

Table 133. Hutchison MediPharma Limited Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 134. Hutchison MediPharma Limited Follicular Lymphoma Treatment Product Offered

Table 135. Hutchison MediPharma Limited Main Business

Table 136. Hutchison MediPharma Limited Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 137. Hutchison MediPharma Limited Latest Developments

Table 138. Immune Design Corp. Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 139. Immune Design Corp. Follicular Lymphoma Treatment Product Offered

Table 140. Immune Design Corp. Main Business

Table 141. Immune Design Corp. Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 142. Immune Design Corp. Latest Developments

Table 143. ImmunoGen, Inc. Details, Company Type, Follicular Lymphoma Treatment Area Served and Its Competitors

Table 144. ImmunoGen, Inc. Follicular Lymphoma Treatment Product Offered

Table 145. ImmunoGen, Inc. Main Business

Table 146. ImmunoGen, Inc. Follicular Lymphoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 147. ImmunoGen, Inc. Latest Developments

List of Figures

Figure 1. Follicular Lymphoma Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Follicular Lymphoma Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Follicular Lymphoma Treatment Market Size Market Share by Type in 2021

Figure 7. Follicular Lymphoma Treatment in Hospital

Figure 8. Global Follicular Lymphoma Treatment Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Follicular Lymphoma Treatment in Clinic

Figure 10. Global Follicular Lymphoma Treatment Market: Clinic (2017-2022) & ($ Millions)

Figure 11. Follicular Lymphoma Treatment in Others

Figure 12. Global Follicular Lymphoma Treatment Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Follicular Lymphoma Treatment Market Size Market Share by Application in 2021

Figure 14. Global Follicular Lymphoma Treatment Revenue Market Share by Player in 2021

Figure 15. Global Follicular Lymphoma Treatment Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Follicular Lymphoma Treatment Market Size 2017-2022 ($ Millions)

Figure 17. APAC Follicular Lymphoma Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Europe Follicular Lymphoma Treatment Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Follicular Lymphoma Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Americas Follicular Lymphoma Treatment Value Market Share by Country in 2021

Figure 21. Americas Follicular Lymphoma Treatment Consumption Market Share by Type in 2021

Figure 22. Americas Follicular Lymphoma Treatment Market Size Market Share by Application in 2021

Figure 23. United States Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Follicular Lymphoma Treatment Market Size Market Share by Region in 2021

Figure 28. APAC Follicular Lymphoma Treatment Market Size Market Share by Application in 2021

Figure 29. China Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Follicular Lymphoma Treatment Market Size Market Share by Country in 2021

Figure 36. Europe Follicular Lymphoma Treatment Market Size Market Share by Type in 2021

Figure 37. Europe Follicular Lymphoma Treatment Market Size Market Share by Application in 2021

Figure 38. Germany Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Follicular Lymphoma Treatment Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Follicular Lymphoma Treatment Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Follicular Lymphoma Treatment Market Size Market Share by Application in 2021

Figure 46. Egypt Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Follicular Lymphoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 52. APAC Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 53. Europe Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 55. United States Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Canada Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 59. China Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Japan Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Korea Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 63. India Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Australia Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Germany Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 66. France Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 67. UK Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Italy Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Russia Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Spain Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Israel Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Follicular Lymphoma Treatment Market Size 2023-2028 ($ Millions)